Sterile Injectable Drugs Market Segmented By Oncology Sterile Injectable Drugs, Generic Sterile Injectable, Drug Injection, Self-injectable Drugs
Industry: Healthcare
Published Date: January-2017
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 249
Report ID: PMRREP12811
1. Executive Summary
2. Market Introduction
2.1. Market Definition
2.2. Market Taxonomy
3. Global Sterile Injectable Drugs Market Analysis Scenario
3.1. Market Size (US$ Bn) and Forecast
3.1.1. Market Size and Y-o-Y Growth
3.1.2. Absolute $ Opportunity
3.2. Market Overview
3.2.1. Value Chain
4. Market Dynamics
4.1. Macro-economic Factors
4.2. Drivers
4.2.1. Supply Side
4.2.2. Demand Side
4.3. Restraints
4.4. Opportunity
4.5. Forecast Factors – Relevance and Impact
4.6. Patent Expiries
5. Global Sterile Injectable Drugs Market Analysis and Forecasts, By Molecules
5.1. Introduction
5.2. Basis Point Share (BPS) Analysis By Molecules Type
5.3. Y-o-Y Growth Projections By Molecules Type
5.4. Market Value Forecast By Molecules, 2016–2024
5.4.1. Large Molecules
5.4.2. Small Molecules
5.5. Market Attractiveness By Molecules
6. Global Sterile Injectable Drugs Market Analysis and Forecasts, By Drugs
6.1. Introduction
6.2. Basis Point Share (BPS) Analysis By Drugs
6.3. Y-o-Y Growth Projections By Drugs
6.4. Market Value Forecast By Drugs , 2016–2024
6.4.1. Monoclonal Antibodies (Mabs)
6.4.2. Cytokines
6.4.3. Insulin
6.4.4. Peptide Hormones
6.4.5. Vaccines
6.4.6. Immunoglobulins
6.4.7. Blood Factors
6.4.8. Peptide Antibiotics
6.4.9. Others
6.5. Market Attractiveness By Drugs
7. Global Sterile Injectable Drugs Market Analysis and Forecasts, By Application
7.1. Introduction
7.2. Basis Point Share (BPS) Analysis By Application
7.3. Y-o-Y Growth Projections By Application
7.4. Market Value Forecast By Application, 2016–2024
7.4.1. Cancer
7.4.2. Diabetes
7.4.3. Cardiovascular Diseases
7.4.4. Musculoskeletal
7.4.5. CNS
7.4.6. Infections
7.4.7. Others
7.5. Market Attractiveness By Application
8. Global Sterile Injectable Drugs Market Analysis and Forecasts, By Route of Administration
8.1. Introduction
8.2. Basis Point Share (BPS) Analysis By Route of Administration
8.3. Y-o-Y Growth Projections By Route of Administration
8.4. Market Value Forecast By Route of Administration, 2016–2024
8.4.1. Intravenous (IV)
8.4.2. Intramuscular (IM)
8.4.3. Subcutaneous (SC)
8.4.4. Others
8.5. Market Attractiveness By Route of Administration
9. Global Sterile Injectable Drugs Market Analysis and Forecasts, By Distribution Channel
9.1. Introduction
9.2. Basis Point Share (BPS) Analysis By Distribution Channel
9.3. Y-o-Y Growth Projections By Distribution Channel
9.4. Market Value Forecast By Distribution Channel , 2019–2024
9.4.1. Hospitals Pharmacies
9.4.2. Retail Pharmacies
9.4.3. Online Pharmacies
9.5. Market Attractiveness By Distribution Channel
10. Global Sterile Injectable Drugs Market Analysis and Forecasts, By Region
10.1. Basis Point Share (BPS) Analysis By Region
10.2. Y-o-Y Growth Projections By Region
10.3. Market Value Forecast By Region
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. APEJ
10.3.5. MEA
10.4. Market Attractiveness By Region
11. North America Sterile Injectable Drugs Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis By Country
11.1.2. Y-o-Y Growth Projections By Country
11.2. Market Value Forecast By Molecules, 2016–2024
11.2.1. Large Molecules
11.2.2. Small Molecules
11.3. Market Value Forecast By Distribution Channel , 2016–2024
11.3.1. Hospitals Pharmacies
11.3.2. Retail Pharmacies
11.3.3. Online Pharmacies
11.4. Market Value Forecast By Drugs , 2016–2024
11.4.1. Monoclonal Antibodies (Mabs)
11.4.2. Cytokines
11.4.3. Insulin
11.4.4. Peptide Hormones
11.4.5. Vaccines
11.4.6. Immunoglobulins
11.4.7. Blood Factors
11.4.8. Peptide Antibiotics
11.4.9. Others
11.5. Market Value Forecast By Application, 2016–2024
11.5.1. Cancer
11.5.2. Diabetes
11.5.3. Cardiovascular Diseases
11.5.4. Musculoskeletal
11.5.5. CNS
11.5.6. Infections
11.5.7. Others
11.6. Market Value Forecast By Route of Administration, 2016–2024
11.6.1. Intravenous (IV)
11.6.2. Intramuscular (IM)
11.6.3. Subcutaneous (SC)
11.6.4. Others
11.7. Market Value Forecast By Country, 2016–2024
11.7.1. US
11.7.2. Canada
11.8. Market Attractiveness Analysis
11.8.1. By Molecules
11.8.2. By Distribution Channel
11.8.3. By Drugs
11.8.4. By Application
11.8.5. By Route of Administration
11.8.6. By Country
11.9. Prominent Trends
12. Latin America Sterile Injectable Drugs Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis By Country
12.1.2. Y-o-Y Growth Projections By Country
12.2. Market Value Forecast By Molecules, 2016–2024
12.2.1. Large Molecules
12.2.2. Small Molecules
12.3. Market Value Forecast By Distribution Channel , 2016–2024
12.3.1. Hospitals Pharmacies
12.3.2. Retail Pharmacies
12.3.3. Online Pharmacies
12.4. Market Value Forecast By Drugs , 2016–2024
12.4.1. Monoclonal Antibodies (Mabs)
12.4.2. Cytokines
12.4.3. Insulin
12.4.4. Peptide Hormones
12.4.5. Vaccines
12.4.6. Immunoglobulins
12.4.7. Blood Factors
12.4.8. Peptide Antibiotics
12.4.9. Others
12.5. Market Value Forecast By Application, 2016–2024
12.5.1. Cancer
12.5.2. Diabetes
12.5.3. Cardiovascular Diseases
12.5.4. Musculoskeletal
12.5.5. CNS
12.5.6. Infections
12.5.7. Others
12.6. Market Value Forecast By Route of Administration, 2016–2024
12.6.1. Intravenous (IV)
12.6.2. Intramuscular (IM)
12.6.3. Subcutaneous (SC)
12.6.4. Others
12.7. Market Value Forecast By Country, 2016–2024
12.7.1. Brazil
12.7.2. Mexico
12.7.3. Rest of Latin America
12.8. Market Attractiveness Analysis
12.8.1. By Molecules
12.8.2. By Distribution Channel
12.8.3. By Drugs
12.8.4. By Application
12.8.5. By Route of Administration
12.8.6. By Country
12.9. Prominent Trends
13. Europe Sterile Injectable Drugs Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis By Country
13.1.2. Y-o-Y Growth Projections By Country
13.2. Market Value Forecast By Molecules, 2016–2024
13.2.1. Large Molecules
13.2.2. Small Molecules
13.3. Market Value Forecast By Distribution Channel , 2016–2024
13.3.1. Hospitals Pharmacies
13.3.2. Retail Pharmacies
13.3.3. Online Pharmacies
13.4. Market Value Forecast By Drugs , 2016–2024
13.4.1. Monoclonal Antibodies (Mabs)
13.4.2. Cytokines
13.4.3. Insulin
13.4.4. Peptide Hormones
13.4.5. Vaccines
13.4.6. Immunoglobulins
13.4.7. Blood Factors
13.4.8. Peptide Antibiotics
13.4.9. Others
13.5. Market Value Forecast By Application, 2016–2024
13.5.1. Cancer
13.5.2. Diabetes
13.5.3. Cardiovascular Diseases
13.5.4. Musculoskeletal
13.5.5. CNS
13.5.6. Infections
13.5.7. Others
13.6. Market Value Forecast By Route of Administration, 2016–2024
13.6.1. Intravenous (IV)
13.6.2. Intramuscular (IM)
13.6.3. Subcutaneous (SC)
13.6.4. Others
13.7. Market Value Forecast By Country, 2016–2024
13.7.1. UK
13.7.2. France
13.7.3. Germany
13.7.4. Italy
13.7.5. Spain
13.7.6. Russia
13.7.7. Rest of Europe
13.8. Market Attractiveness Analysis
13.8.1. By Molecules
13.8.2. By Distribution Channel
13.8.3. By Drugs
13.8.4. By Application
13.8.5. By Route of Administration
13.8.6. By Country
13.9. Prominent Trends
14. APEJ Sterile Injectable Drugs Market Analysis and Forecast
14.1. Introduction
14.1.1. Basis Point Share (BPS) Analysis By Country
14.1.2. Y-o-Y Growth Projections By Country
14.2. Market Value Forecast By Molecules, 2016–2024
14.2.1. Large Molecules
14.2.2. Small Molecules
14.3. Market Value Forecast By Distribution Channel , 2016–2024
14.3.1. Hospitals Pharmacies
14.3.2. Retail Pharmacies
14.3.3. Online Pharmacies
14.4. Market Value Forecast By Drugs , 2016–2024
14.4.1. Monoclonal Antibodies (Mabs)
14.4.2. Cytokines
14.4.3. Insulin
14.4.4. Peptide Hormones
14.4.5. Vaccines
14.4.6. Immunoglobulins
14.4.7. Blood Factors
14.4.8. Peptide Antibiotics
14.4.9. Others
14.5. Market Value Forecast By Application, 2016–2024
14.5.1. Cancer
14.5.2. Diabetes
14.5.3. Cardiovascular Diseases
14.5.4. Musculoskeletal
14.5.5. CNS
14.5.6. Infections
14.5.7. Others
14.6. Market Value Forecast By Route of Administration, 2016–2024
14.6.1. Intravenous (IV)
14.6.2. Intramuscular (IM)
14.6.3. Subcutaneous (SC)
14.6.4. Others
14.7. Market Value Forecast By Country, 2016–2024
14.7.1. Japan
14.7.2. China
14.7.3. India
14.7.4. Australia & New Zealand
14.7.5. ASEAN
14.7.6. Rest of APAC
14.8. Market Attractiveness Analysis
14.8.1. By Molecules
14.8.2. By Distribution Channel
14.8.3. By Drugs
14.8.4. By Application
14.8.5. By Route of Administration
14.8.6. By Country
14.9. Prominent Trends
15. MEA Sterile Injectable Drugs Market Analysis and Forecast
15.1. Introduction
15.1.1. Basis Point Share (BPS) Analysis By Country
15.1.2. Y-o-Y Growth Projections By Country
15.2. Market Value Forecast By Molecules, 2016–2024
15.2.1. Large Molecules
15.2.2. Small Molecules
15.3. Market Value Forecast By Distribution Channel , 2016–2024
15.3.1. Hospitals Pharmacies
15.3.2. Retail Pharmacies
15.3.3. Online Pharmacies
15.4. Market Value Forecast By Drugs , 2016–2024
15.4.1. Monoclonal Antibodies (Mabs)
15.4.2. Cytokines
15.4.3. Insulin
15.4.4. Peptide Hormones
15.4.5. Vaccines
15.4.6. Immunoglobulins
15.4.7. Blood Factors
15.4.8. Peptide Antibiotics
15.4.9. Others
15.5. Market Value Forecast By Application, 2016–2024
15.5.1. Cancer
15.5.2. Diabetes
15.5.3. Cardiovascular Diseases
15.5.4. Musculoskeletal
15.5.5. CNS
15.5.6. Infections
15.5.7. Others
15.6. Market Value Forecast By Route of Administration, 2016–2024
15.6.1. Intravenous (IV)
15.6.2. Intramuscular (IM)
15.6.3. Subcutaneous (SC)
15.6.4. Others
15.7. Market Value Forecast By Country, 2016–2024
15.7.1. GCC Countries
15.7.2. South Africa
15.7.3. North Africa
15.7.4. Rest of MEA
15.8. Market Attractiveness Analysis
15.8.1. By Molecules
15.8.2. By Distribution Channel
15.8.3. By Drugs
15.8.4. By Application
15.8.5. By Route of Administration
15.8.6. By Country
15.9. Prominent Trends
16. Competition Landscape
16.1. Competition Dashboard
16.2. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
16.2.1. Baxter International Inc.
16.2.2. Sanofi
16.2.3. Pfizer Inc.
16.2.4. GlaxoSmithKline plc.
16.2.5. AstraZeneca
16.2.6. GILEAD SCIENCES, INC.
16.2.7. Merck & Co., Inc.
16.2.8. Novartis AG
16.2.9. Johnson & Johnson Services, Inc.
16.2.10. Nova Nordisk A/S
17. Assumptions and Acronyms Used
18. Research Methodology
Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
List of Tables
Table 01: Global Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Molecule Type, 2015–2024
Table 02: Global Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Drug Type, 2015–2024
Table 03: Global Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Application Type, 2015–2024
Table 04: Global Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Routes of Administration, 2015–2024
Table 05: Global Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Distribution Channel, 2015–2024
Table 06: Global Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Region, 2015–2024
Table 07: North America Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Country, 2015–2024
Table 08: North America Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Molecule Type, 2015–2024
Table 09: North America Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Drug Type, 2015–2024
Table 10: North America Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Application Type, 2015–2024
Table 11: North America Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Routes of Administration, 2015–2024
Table 12: North America Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Distribution Channel,
Table 13: Latin America Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Country, 2015–2024
Table 14: Latin America Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Molecule Type, 2015–2024
Table 15: Latin America Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Drug Type, 2015–2024
Table 16: Latin America Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Application Type, 2015–2024
Table 17: Latin America Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Routes of Administration, 2015–2024
Table 18: Latin America Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Distribution Channel,
Table 19: Europe Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Country, 2015–2024
Table 20: Europe Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Molecule Type, 2015–2024
Table 21: Europe Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Drug Type, 2015–2024
Table 22: Europe Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Application Type, 2015–2024
Table 23: Europe Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Routes of Administration, 2015–2024
Table 24: Europe Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Distribution Channel, 2015–2024
Table 25: APAC Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Country, 2015–2024
Table 26: APAC Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Molecule Type, 2015–2024
Table 27: APAC Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Drug Type, 2015–2024
Table 28: APAC Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Application Type, 2015–2024
Table 29: APAC Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Routes of Administration, 2015–2024
Table 30: APAC Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Distribution Channel, 2015–2024
Table 31: MEA Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Country, 2015–2024
Table 32: MEA Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Molecule Type, 2015–2024
Table 33: MEA Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Drug Type, 2015–2024
Table 34: MEA Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Application Type, 2015–2024
Table 35: MEA Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Routes of Administration, 2015–2024
Table 36: MEA Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Distribution Channel, 2015–2024
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version
List of Figures
Figure 01: Global Sterile Injectable Drugs Market – Scenario Forecast, 2016–2024 (US$ Bn)
Figure 02 : Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024
Figure 03 : Global Sterile Injectable Drugs Market Absolute $ Opportunity, 2016–2024
Figure 04 : Global Sterile Injectable Drugs Market Share Analysis (%) By Molecule Type, 2016 & 2024
Figure 05 : Global Sterile Injectable Drugs Y-o-Y growth (%) By Molecule Type, 2016–2024
Figure 06: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Small Molecules Segment, 2015–2024
Figure 07: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Small Molecules Segment, 2016–2024
Figure 08: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Large Molecules Segment, 2015–2024
Figure 09: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Large Molecules Segment, 2016–2024
Figure 10: Global Sterile Injectable Drugs Market Attractiveness Analysis By Molecule Type, 2016–2024
Figure 11: Global Sterile Injectable Drugs Market Share Analysis (%) By Drug Type, 2016 & 2024
Figure 12: Global Sterile Injectable Drugs Y-o-Y growth (%) By Drug Type, 2016–2024
Figure 13: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Monoclonal Antibodies (mAbs) Segment, 2015–2024
Figure 14: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Monoclonal Antibodies (mAbs) Segment, 2016–2024
Figure 15: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Cytokines Segment, 2015–2024
Figure 16: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Cytokines Segment, 2016–2024
Figure 17: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Insulin Segment, 2015–2024
Figure 18: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Insulin Segment, 2016–2024
Figure 19: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Peptide Hormones Segment, 2015–2024
Figure 20: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Peptide Hormones Segment, 2016–2024
Figure 21: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) Vaccines Segment, 2015–2024
Figure 22: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Vaccines Segment, 2016–2024
Figure 23: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Immunoglobulins Segment, 2015–2024
Figure 24: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Immunoglobulins Segment, 2016–2024
Figure 25: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Blood Factors Segment, 2015–2024
Figure 26: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Blood Factors Segment, 2016–2024
Figure 27: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Peptide Antibiotics Segment,2015–2024
Figure 28: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Peptide Antibiotics Segment, 2016–2024
Figure 29: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Others Segment, 2015–2024
Figure 30: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Others Segment, 2016–2024
Figure 31: Global Sterile Injectable Drugs Market Attractiveness Analysis By Drug Type, 2016–2024
Figure 32: Global Sterile Injectable Drugs Market Share Analysis (%) By Application, 2016 & 2024
Figure 33: Global Sterile Injectable Drugs Y-o-Y growth (%) By Application, 2016–2024
Figure 34: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Cancer Segment, 2015–2024
Figure 35: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Cancer Segment, 2016–2024
Figure 36: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Diabetes Segment, 2015–2024
Figure 37: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Diabetes Segment, 2016–2024
Figure 38: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Cardiovascular Diseases Segment,2015–2024
Figure 39: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Cardiovascular Diseases Segment, 2016–2024
Figure 40: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Musculoskeletal Segment,2015–2024
Figure 41: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Musculoskeletal Segment, 2016–2024
Figure 42: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By CNS Segment, 2015–2024
Figure 43: Global Sterile Injectable Drugs Market Absolute $ Opportunity By CNS Segment, 2016–2024
Figure 44: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Infections Segment, 2015–2024
Figure 45: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Infections Segment, 2016–2024
Figure 46: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Others Segment, 2015–2024
Figure 47: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Others Segment, 2016–2024
Figure 48: Global Sterile Injectable Drugs Market Attractiveness Analysis By Application Type, 2016–2024
Figure 49: Global Sterile Injectable Drugs Market Share Analysis (%) By Routes of Administration, 2016 & 2024
Figure 50: Global Sterile Injectable Drugs Y-o-Y growth (%) By Routes of Administration, 2016–2024
Figure 51: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Intravenous (IV) Segment,2015–2024
Figure 52: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Intravenous (IV) Segment, 2016–2024
Figure 53: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Intramuscular (IM) Segment, 2015–2024
Figure 54: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Intramuscular (IM) Segment, 2016–2024
Figure 55: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Subcutaneous (SC) Segment, 2015–2024
Figure 56: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Subcutaneous (SC) Segment, 2016–2024
Figure 57: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Others Segment, 2015–2024
Figure 58: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Others Segment, 2016–2024
Figure 59: Global Sterile Injectable Drugs Market Attractiveness Analysis By Routes of Administration, 2016–2024
Figure 60: Global Sterile Injectable Drugs Market Share Analysis (%) By Distribution Channel, 2016 & 2024
Figure 61: Global Sterile Injectable Drugs Y-o-Y growth (%) By Distribution Channel, 2016–2024
Figure 62: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Hospital Pharmacies Segment, 2015–2024
Figure 63: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Hospital Pharmacies Segment, 2016–2024
Figure 64: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Retail Pharmacies Segment, 2015–2024
Figure 65: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Retail Pharmacies Segment, 2016–2024
Figure 66: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Online Pharmacies Segment, 2015–2024
Figure 67: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Online Pharmacies Segment, 2016–2024
Figure 68: Global Sterile Injectable Drugs Market Attractiveness Analysis By Distribution Channel, 2016–2024
Figure 69: Global Sterile Injectable Drugs Market Share Analysis (%) By Region, 2016 & 2024
Figure 70: Global Sterile Injectable Drugs Y-o-Y growth (%) By Region, 2016–2024
Figure 71: North America Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024
Figure 72: North America Sterile Injectable Drugs Market Absolute $ Opportunity, 2016–2024
Figure 73: Latin America Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024
Figure 74: Latin America Sterile Injectable Drugs Market Absolute $ Opportunity, 2016–2024
Figure 75: Europe Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024
Figure 76: Europe Sterile Injectable Drugs Market Absolute $ Opportunity, 2016–2024
Figure 77: APAC Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024
Figure 78: APAC Sterile Injectable Drugs Market Absolute $ Opportunity, 2016–2024
Figure 79: MEA Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024
Figure 80: MEA Sterile Injectable Drugs Market Absolute $ Opportunity, 2016–2024
Figure 81: Global Sterile Injectable Drugs Market Attractiveness Analysis By Region, 2016–2024
Figure 82: North America Sterile Injectable Drugs Market Share Analysis (%) By Country, 2016 & 2024
Figure 83: North America Sterile Injectable Drugs Y-o-Y growth (%) By Country, 2016–2024
Figure 84: U.S. Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024
Figure 85: U.S. Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016–2024
Figure 86: Canada Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024
Figure 87: Canada Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn) 2016–2024
Figure 88: North America Sterile Injectable Drugs Market Attractiveness Analysis By Country, 2016–2024
Figure 89: North America Sterile Injectable Drugs Market Attractiveness Analysis By Molecule type, 2016–2024
Figure 90: North America Sterile Injectable Drugs Market Attractiveness Analysis By Drug Type, 2016–2024
Figure 91: North America Sterile Injectable Drugs Market Attractiveness Analysis By Application Type, 2016–2024
Figure 92: North America Sterile Injectable Drugs Market Attractiveness Analysis By Routes of Administration, 2016–2024
Figure 93: North America Sterile Injectable Drugs Market Attractiveness Analysis By Distribution Channel, 2016–2024
Figure 94: Latin America Sterile Injectable Drugs Market Share Analysis (%) By Country, 2016 & 2024
Figure 95: Latin America Sterile Injectable Drugs Y-o-Y growth (%) By Country, 2016–2024
Figure 96: Brazil Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024
Figure 97: Brazil Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016–2024
Figure 98: Mexico Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024
Figure 99: Mexico Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016–2024
Figure 100: Rest of Latin America Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024
Figure 101: Rest of Latin America Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016–2024
Figure 102: Latin America Sterile Injectable Drugs Market Attractiveness Analysis By Country, 2016–2024
Figure 103: Latin America Sterile Injectable Drugs Market Attractiveness Analysis By Molecule type, 2016–2024
Figure 104: Latin America Sterile Injectable Drugs Market Attractiveness Analysis By Drug Type, 2016–2024
Figure 105: Latin America Sterile Injectable Drugs Market Attractiveness Analysis By Application Type, 2016–2024
Figure 106: Latin America Sterile Injectable Drugs Market Attractiveness Analysis By Routes of Administration, 2016–2024
Figure 107: Latin America Sterile Injectable Drugs Market Attractiveness Analysis By Distribution Channel, 2016–2024
Figure 108: Europe Sterile Injectable Drugs Market Share Analysis (%) By Country, 2016 & 2024
Figure 109: Europe Sterile Injectable Drugs Y-o-Y growth (%) By Country, 2016–2024
Figure 110: Germany Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024
Figure 111: Germany Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016–2024
Figure 112: France Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024
Figure 113: France Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016–2024
Figure 114: Russia Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024
Figure 115: Russia Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016–2024
Figure 116: Italy Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024
Figure 117: Italy Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016–2024
Figure 118: Spain Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024
Figure 119: Spain Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016–2024
Figure 120: U.K. Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024
Figure 121: U.K. Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016–2024
Figure 122: Rest of Europe Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024
Figure 123: Rest of Europe Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016–2024
Figure 124: Europe Sterile Injectable Drugs Market Attractiveness Analysis By Country, 2016–2024
Figure 125: Europe Sterile Injectable Drugs Market Attractiveness Analysis By Molecule type, 2016–2024
Figure 126: Europe Sterile Injectable Drugs Market Attractiveness Analysis By Drug Type, 2016–2024
Figure 127: Europe Sterile Injectable Drugs Market Attractiveness Analysis By Application Type, 2016–2024
Figure 128: Europe Sterile Injectable Drugs Market Attractiveness Analysis By Routes of Administration, 2016–2024
Figure 129: Europe Sterile Injectable Drugs Market Attractiveness Analysis By Distribution Channel, 2016–2024
Figure 130: APAC Sterile Injectable Drugs Market Share Analysis (%) By Country, 2016 & 2024
Figure 131: APAC Sterile Injectable Drugs Y-o-Y growth (%) By Country, 2016–2024
Figure 132: China Sterile Injectable Drugs Market Value
Figure 133: China Sterile Injectable Drugs Market Absolute $ Opportunity (US$), 2016–2024
Figure 134: India Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024
Figure 135: India Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016–2024
Figure 136: Japan Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024
Figure 137: Japan Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016–2024
Figure 138: Australia & New Zealand Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024
Figure 139: Australia & New Zealand Sterile Injectable Drugs Market Absolute $ Opportunity, 2016–2024
Figure 140: ASEAN Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024
Figure 141: ASEAN Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016–2024
Figure 142: Rest of APAC Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024
Figure 143: Rest of APAC Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016–2024
Figure 144: APAC Sterile Injectable Drugs Market Attractiveness Analysis By Country, 2016–2024
Figure 145: APAC Sterile Injectable Drugs Market Attractiveness Analysis By Molecule type, 2016–2024
Figure 146: APAC Sterile Injectable Drugs Market Attractiveness Analysis By Drug Type, 2016–2024
Figure 147: APAC Sterile Injectable Drugs Market Attractiveness Analysis By Application Type, 2016–2024
Figure 148: APAC Sterile Injectable Drugs Market Attractiveness Analysis By Routes of Administration, 2016–2024
Figure 149: APAC Sterile Injectable Drugs Market Attractiveness Analysis By Distribution Channel, 2016–2024
Figure 150: MEA Sterile Injectable Drugs Market Share Analysis (%) By Country, 2016 & 2024
Figure 151: MEA Sterile Injectable Drugs Y-o-Y growth (%) By Country, 2016–2024
Figure 152: GCC Countries Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024
Figure 153: GCC Countries Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016–2024
Figure 154: South Africa Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024
Figure 155: South Africa Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn) 2016–2024
Figure 156: North Africa Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024
Figure 157: North Africa Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn) 2016–2024
Figure 158: Rest of MEA Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015–2024
Figure 159: Rest of MEA Sterile Injectable Drugs Market Absolute $ Opportunity (US$), 2016–2024
Figure 160: MEA Sterile Injectable Drugs Market Attractiveness Analysis By Country, 2016–2024
Figure 161: MEA Sterile Injectable Drugs Market Attractiveness Analysis By Molecule type, 2016–2024
Figure 162: MEA Sterile Injectable Drugs Market Attractiveness Analysis By Drug Type, 2016–2024
Figure 163: MEA Sterile Injectable Drugs Market Attractiveness Analysis By Application Type, 2016–2024
Figure 164: MEA Sterile Injectable Drugs Market Attractiveness Analysis By Routes of Administration, 2016–2024
Figure 165: MEA Sterile Injectable Drugs Market Attractiveness Analysis By Distribution Channel, 2016–2024
